Abstract:Viral myocarditis (VMC) is a life-threatening disease characterized by severe cardiac inflammation generally caused by coxsackievirus B3 (CVB3) infection. Several microRNAs (miRNAs or miRs) are known to play crucial roles in the pathogenesis of VMC. The study aimed to decipher the role of miR-30a-5p in the underlying mechanisms of VMC pathogenesis. We first quantified miR-30a-5p expression in a CVB3-induced mouse VMC model. The physiological characteristics of mouse cardiac tissues were then detected by hematoxylin and eosin (HE) and Picrosirius red staining. We established the correlation between miR-30a-5p and SOCS1, using dual-luciferase gene assay and Pearson's correlation coefficient. The expression of inflammatory factors (IFN-γ, IL-6, IL-10, and IL-13), M1 polarization markers [TNF-α, inducible nitric oxide synthase (iNOS)], M2 polarization markers (Arg-1, IL-10), and myocardial hypertrophy markers [atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP)] was detected by RT-qPCR and Western blot analysis. miR-30a-5p was found to be highly expressed in VMC mice. Silencing of miR-30a-5p improved the cardiac function index and reduced heart weight-to-body weight ratio, myocardial tissue pathological changes and fibrosis degree, serological indexes, as well as proinflammatory factor levels, while enhancing anti-inflammatory factor levels in VMC mice. Furthermore, silencing of miR-30a-5p inhibited M1 polarization of macrophages while promoting M2 polarization in vivo and in vitro. SOCS1 was a target gene of miR-30a-5p, and the aforementioned cardioprotective effects of miR-30a-5p silencing were reversed upon silencing of SOCS1. Overall, this study shows that silencing of miR-30a-5p may promote M2 polarization of macrophages and improve cardiac injury following VMC via SOCS1 upregulation, constituting a potential therapeutic target for VMC treatment.NEW & NOTEWORTHY We found in this study that microRNA (miR)-30a-5p inhibition might improve cardiac injury following viral myocarditis (VMC) by accelerating M2 polarization of macrophages via SOCS1 upregulation. Furthermore, the anti-inflammatory mechanisms of miR-30a-5p inhibition may contribute to the development of new therapeutic strategies for VMC.

Microrna-19b Downregulates Gap Junction Protein Alpha1 And Synergizes With Microrna-1 In Viral Myocarditis

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

[The Expression of Connexin 43 and Desmin in Viral Myocarditis].

MicroRNA- 1 represses Cx43 expression in viral myocarditis

Weighted Gene Co-Expression Network Analysis Identified Underlying Hub Genes and Mechanisms in the Occurrence and Development of Viral Myocarditis

MicroRNA‑21 regulation of the progression of viral myocarditis to dilated cardiomyopathy.

Cardiac Mir-19A/19b Was Induced and Hijacked by CVB3 to Facilitate Virus Replication Via Targeting Viral Genomic RdRp-encoding Region.

MicroRNA-20b Suppresses the Expression of ZFP-148 in Viral Myocarditis

Dysregulated Expression of Micrornas and Mrnas in Myocardial Infarction.

Hsa-circ-ACSL1 Enhances Apoptosis and Autophagy in Myocarditis Cardiomyocytes Through the miR-7-5p/XBP1 Axis

miR-19b-3p/PKNOX1 Regulates Viral Myocarditis by Regulating Macrophage Polarization

A20 (TNFAIP3) alleviates viral myocarditis through ADAR1/miR-1a-3p-dependent regulation

MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1

miR-29b-3p regulates cardiomyocytes pyroptosis in CVB3-induced myocarditis through targeting DNMT3A

Therapeutic Role of Mir-19A/19b in Cardiac Regeneration and Protection from Myocardial Infarction

Identification of Cardiac CircRNAs in Mice With CVB3-Induced Myocarditis

Mir-1231 Exacerbates Arrhythmia by Targeting Calciumchannel Gene CACNA2D2 in Myocardial Infarction.

The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis

Analysis of microRNA expression profiles in CVB3-induced myocarditis

MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis.

LncRNA XIST Knockdown Reduces Myocardial Damage in Myocarditis by Targeting the Mir-140-3p/ripk1 Axis